^
    3ms
    QTX3034-001: QTX3034 in Patients With KRAS G12D Mutation (clinicaltrials.gov)
    P1, N=250, Recruiting, Quanta Therapeutics | Not yet recruiting --> Recruiting
    Enrollment open
    |
    KRAS (KRAS proto-oncogene GTPase)
    |
    Erbitux (cetuximab) • QTX3034
    4ms
    QTX3034-001: Evaluate QTX3034 in Patients With KRAS G12D Mutation (clinicaltrials.gov)
    P1, N=250, Not yet recruiting, Quanta Therapeutics
    New P1 trial
    |
    KRAS (KRAS proto-oncogene GTPase)
    |
    Erbitux (cetuximab) • QTX3034